Emvision Medical Devices (ASX:EMV)
ASX announcement history & article coverage
Transparent by design.
Announcments by Emvision Medical Devices (ASX:EMV) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
emu Regional Benefits Study Advancing
EMVision advances regional stroke diagnosis study with CRC-P funding and site visits complete
emu Pivotal Trial Recruitment Surpasses 200 Patients
EMVision surpasses 200 patients in emu™ brain scanner pivotal trial, advancing FDA clearance pathway
FY26 Results Presentation
Appendix 4G & Corporate Governance Statement
Appendix 4E & Annual Report to 30 June 2026
EMVision reports FY26 progress with increased revenue, reduced loss, and advances in brain scanner trials
Change of Registered Office Address
Quarterly Activities/Appendix 4C Cash Flow Report
EMVision advances brain scanner trials, secures $17.1m cash, and expands clinical applications
emu AI methods & insights published in npj Digital Medicine